Sun Pharma Finalizes Acquisition of Checkpoint Therapeutics Enhancing Cancer Treatment Options Sun Pharmaceutical Industries has successfully acquired Checkpoint Therapeutics, gaining access to UNLOXCYT™, an FDA-approved treatment for skin cancer, marking a significant step forward in oncology.

Sun Pharma Finalizes Acquisition of Checkpoint Therapeutics Enhancing Cancer Treatment Options #India #Mumbai #UNLOXCYT #Checkpoint_Therapeutics #Sun_Pharmaceutical

Checkpoint Therapeutics Shareholders: Investigating Sale to Sun Pharma and Potential Conflicts Julie & Holleman LLP is examining the $4.10 per share sale of Checkpoint Therapeutics to Sun Pharma, raising concerns over shareholder interests.

Checkpoint Therapeutics Shareholders: Investigating Sale to Sun Pharma and Potential Conflicts #United_States #New_York #Julie_&_Holleman #Checkpoint_Therapeutics #Fortress_Biotech